Bas Wijnhoven

Bas Wijnhoven is a Full Professor in the Department of Surgery at Erasmus MC, specializing in surgical oncology with a focus on esophageal and gastrointestinal cancers. He is actively involved in high-impact clinical research and leads major collaborative studies such as the SANO and IVORY trial groups.

His research interests include:

• Esophageal cancer and neoadjuvant chemoradiotherapy
• Esophagectomy and surgical outcomes
• Pathological complete response as a surrogate endpoint
• Nationwide surgical audits and quality improvement
• Gastrointestinal malignancies and abdominal oncology

His recent publications demonstrate a consistent focus on clinical trials, survival analysis, and population-level surgical outcomes, particularly in upper gastrointestinal cancers. Work appears in top journals including The Lancet Oncology and British Journal of Surgery.

He has supervised multiple trainees, as indicated by 19 supervised works, though specific student names are not listed. His research is highly collaborative, involving national and international study groups.

Besides his clinical and academic roles, he contributes to policy and practice through nationwide audits and guideline-shaping trials. He is an active contributor to the surgical oncology fingerprint, with topics including chemoradiotherapy, gastrectomy, and overall survival.